OLAPLEX, a foundational health and beauty company, announced the acquisition of Purvala Bioscience, a Boston-based biotech company.
This acquisition signifies OLAPLEX's commitment to product innovation and the development of transformative technologies.
Purvala, founded by Dr. Bradley Olsen, focuses on creating high-performing molecules inspired by natural biological structures.
First Acquisition
First acquisition by OLAPLEX since its launch over ten years ago, showcasing its dedication to innovation.
Bioinspired Technologies
Purvala specializes in developing bioinspired technologies for the health and beauty industries.
Leadership and Expertise
Dr. Bradley Olsen, the founder of Purvala and a MIT Professor, brings expertise in chemical engineering to the acquisition.
- The acquisition of Purvala expands OLAPLEX's portfolio of science-backed products and reinforces its commitment to delivering innovative solutions.
- It positions OLAPLEX to create disruptive product innovations with Purvala's technology alongside its existing bond-building expertise.
OLAPLEX's acquisition of Purvala marks a significant milestone in its journey of groundbreaking product development and underscores its mission to deliver exceptional haircare solutions. The partnership with Purvala sets the stage for pioneering advancements in health and beauty products.